Citigroup Inc Abb Vie Inc. Put Options Transaction History

Citigroup Inc

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $19.4 Million - $23.6 Million	118,600 Added 14.49%	936,900 $185 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $6.8 Million - $7.94 Million	43,900 Added 5.67%	818,300 $140 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $5.07 Million - $5.77 Million	31,700 Added 4.27%	774,400 $141 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $5.09 Million - $5.73 Million	37,000 Added 5.24%	742,700 $115 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $7.45 Million - $8.63 Million	-55,800 Reduced 7.33%	705,700 $105 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $55.7 Million - $69.3 Million	420,300 Added 123.18%	761,500 $103 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $18.5 Million - $21.4 Million	-128,200 Reduced 27.31%	341,200 $54.4 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $10 Million - $12 Million	72,300 Added 18.21%	469,400 $75.9 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $10.4 Million - $11.9 Million	-77,500 Reduced 16.33%	397,100 $53.3 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $60.8 Million - $77.3 Million	-441,800 Reduced 48.21%	474,600 $72.7 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $87.1 Million - $108 Million	-660,300 Reduced 41.88%	916,400 $149 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $62.7 Million - $79.3 Million	583,600 Added 58.77%	1,576,700 $213 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $106 Million - $120 Million	993,100 New	993,100 $107 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.